Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology. - Test2 - elhamkhani - TriplyDB

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.

http://www.wikidata.org/entity/Q37129119

about

Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.cepip: context-dependent epigenomic weighting for prioritization of regulatory variants and disease-associated genes.Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3.Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.The Five Dimensions of Parkinson's Disease Genetic Risk.Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype

P2860

Q33734563-849596CF-90BC-4E14-B8B1-1742E3D4389B Q36346103-0EBE8F1D-B961-4EA4-B350-373BD948AA53 Q37708369-F2686A27-8982-416C-BC35-3D3C20C001D7 Q38993596-B62B2C17-C657-4FB5-9AC4-0A7419820A52 Q39137358-8C68260F-4668-4B83-8631-64B95D48149B Q41095173-5AEBF55A-1039-4FA8-B20F-10BDB6992E37 Q43721606-4BE63D1F-C5FE-429D-9101-99F0D6FB0A53 Q47923533-518F8E19-4491-4A2F-BDE6-5B3790352901 Q49652597-7D9B8AA8-42FF-4EA3-AEE1-AED68CE60D27 Q59133037-7051AED9-5940-47BC-B9B2-A36B9170E558

P2860

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.

http://www.wikidata.org/entity/Q37129119

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@en

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@nl

type

label

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@en

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@nl

prefLabel

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@en

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@nl

P1433

Q37129119-C1B5750F-5128-41E8-A9BC-44256C798C3D

P1476

Q37129119-80B0F319-E707-4601-933B-E0D06EF69F2A

P2093

Q37129119-322723C5-00EB-4696-AA3D-AB7CAD476521

Q37129119-329459D2-4775-43F1-9044-C7FFB3DC279A

Q37129119-57980A92-7E7F-43FA-A2A7-44B53A7C4B2D

Q37129119-8C5285F2-445B-43E0-A8FB-0EB6D229CF2A

Q37129119-A906CD21-EDBE-41A4-91B8-1935AA6EA32C

P2860

Q37129119-02A610DE-5732-4781-8CEB-8C17DC1C81F7

Q37129119-03BA76B8-9802-4604-A614-DE8260AADB1D

Q37129119-07CD6F3D-43F3-430D-BB75-75E8DF9FF8B8

Q37129119-0AD8B0D9-D51E-4414-8DF3-2784DC948E45

Q37129119-13B0025C-B6C1-47E0-A1E5-1FB131253BFE

Q37129119-163E53BA-F78C-43CB-B0FD-B2B98A717ECA

Q37129119-194AA3A7-E4E9-418C-9681-53F8BB99ED1C

Q37129119-1D6146F5-31CC-4199-8346-4AD8E8D4A087

Q37129119-207B55A7-4AD4-40D0-B62F-94685AD0C247

Q37129119-263AE80F-C628-4921-A98A-1539A477BE76

P2888

Q37129119-DFFBC2F1-78F9-4768-BE32-B57332524C2E

P304

Q37129119-AA38F49C-4ABA-45B3-857B-F086AC72D3BE

P31

Q37129119-C7566101-851F-41F4-8E50-33ED31B6D09E

P356

Q37129119-F9DEB2E6-0081-43A8-9A70-BC079902C4D2

P407

Q37129119-0C870E09-6351-4F02-823C-30162BB16590

P478

Q37129119-01850B7A-F345-4163-8A5E-BE882E91FCDE

P50

Q37129119-D3CDBE3D-FB3C-45A7-9ADB-AB57464D1DB1

P577

Q37129119-0953CDEE-8449-4A30-A840-180E5D370455

P6179

Q37129119-9DCB6FBD-BF2C-43A8-9B0A-0552C96BF753

P698

Q37129119-6EDEC460-418D-4CCE-BC78-4B220D1D681F

P921

Q37129119-DC3590B3-0682-4418-9A55-0F28FACE5F76

P932

Q37129119-FB3FBD74-7B47-4BC3-8447-0324B878DF57

P356

P1433

Scientific Reports

P1476

Enrichment of risk SNPs in reg ...... Parkinson's disease etiology.

@en

P2093

Dennis J Hazelett

http://www.w3.org/2001/XMLSchema#string

Gerhard A Coetzee

http://www.w3.org/2001/XMLSchema#string

Lena Brundin

http://www.w3.org/2001/XMLSchema#string

Simon G Coetzee

http://www.w3.org/2001/XMLSchema#string

Steven Pierce

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

Genetic and epigenetic fine mapping of causal autoimmune disease variants

Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD

A genome-wide scan for common alleles affecting risk for autism

FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders

Integrative analysis of 111 reference human epigenomes

P2888

P304

30509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP30509

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015800854

http://www.w3.org/2001/XMLSchema#string

P698

27461410

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4962314

http://www.w3.org/2001/XMLSchema#string